Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05962398. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Extension Study Assessing the Long-term Safety and Efficacy of Etranacogene Dezaparvovec (CSL222) Previously Administered to Adult Male Subjects With Hemophilia B
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to assess the long-term safety and efficacy in male adults with hemophilia B who were treated with CSL222 (CSL222) in parent studies CSL222\_2001 (NCT03489291) or CSL222\_3001 (NCT03569891).
Study identification
- NCT ID
- NCT05962398
- Recruitment status
- Enrolling by invitation
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 56 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 30, 2023 (Actual)
- Primary completion
- Mar 23, 2035 (Estimated)
- Completion
- Mar 23, 2035 (Estimated)
- Last update posted
- Jul 18, 2025
2023 – 2035
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 10-15 Phoenix Childrens Hospital | Phoenix | Arizona | 85016 | — |
| 10-14 Arkansas Children's Hospital - Pharmacology | Little Rock | Arkansas | 72202 | — |
| 10-22 Orthopaedic Institute for Children | Los Angeles | California | 90007 | — |
| 10-21 Children's Hospital of Los Angeles | Los Angeles | California | 90027 | — |
| 10-63 UC Davis Medical Center | Sacramento | California | 95817 | — |
| 10-12 University of California, San Diego (UCSD) | San Diego | California | 92121 | — |
| 10-25 University of Colorado Denver | Aurora | Colorado | 80045 | — |
| 10-19 University of South Florida | Tampa | Florida | 33612 | — |
| 10-10 University of Michigan Medical Center | Ann Arbor | Michigan | 48109 | — |
| 10-16 University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| 10-18 Oregon Health & Science University | Portland | Oregon | 97239 | — |
| 10-20 Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| 10-28 University of Texas Health Science Center | Houston | Texas | 77030 | — |
| 10-26 University of Utah | Salt Lake City | Utah | 84108 | — |
| 10-62 Washington Institute for Coagulation | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05962398, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2025 · Synced Nov 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.